Skip to main content
Equibles

MORGAN STANLEY

Position in TCRX — TScan Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$193,932
+$18,554 QoQ
Shares Held
197,891
+14.0% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 60 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TCRX ranks #326 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in TCRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $193,932 197,891
2026-03-31 $175,378 173,643
2025-12-31 $225,829 225,829
2025-09-30 $1,542,515 847,537
2025-06-30 $1,237,350 853,346
2025-03-31 $818,297 592,970
2024-12-31 $1,255,087 412,858
2024-09-30 $1,490,605 299,319
2024-06-30 $1,413,780 241,672
2024-03-31 $1,777,716 223,894
2023-12-31 $1,368,318 234,703
2023-09-30 $664,184 259,447
2023-06-30 $271,187 108,475
2023-03-31 $275,769 131,319
2022-12-31 $65,371 42,175
2022-09-30 $196,938 64,570
2022-06-30 $179,544 57,089
2022-03-31 $109,412 39,076
2021-12-31 $123,317 27,404
2021-09-30 $235,488 28,236